CARL
Carlsmed, Inc.
18.60
+3.89 (+26.44%)
52w low 8.50
17.23 high
100.0% of range
Financial Analysis
| Ratio | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Profitability | |||||||
| Gross Margin | -- | 73.4% | 75.9% | 76.5% | 77.1% | 76.8% | |
| Operating Margin | -- | -53.8% | -69.1% | -61.4% | -57.6% | -58.3% | |
| EBITDA Margin | -- | -52.5% | -61.7% | -54.0% | -51.4% | -53.2% | |
| Net Margin | -- | -56.0% | -65.2% | -56.8% | -54.0% | -55.5% | |
| FCF Margin | -- | -62.8% | -67.3% | -36.6% | -82.0% | -42.8% | |
| Returns | |||||||
| Return on Equity | -- | 8.1% | -8.0% | -8.7% | -9.4% | -12.5% | |
| Return on Assets | -- | -12.7% | -6.3% | -6.6% | -7.3% | -8.9% | |
| Return on Inv Capital | -- | 7.5% | -5.3% | -5.7% | -6.2% | -8.1% | |
| Liquidity | |||||||
| Current Ratio | -- | 4.87x | 12.03x | 8.87x | 11.88x | 8.84x | |
| Quick Ratio | -- | 4.76x | 11.91x | 8.74x | 11.67x | 8.66x | |
| Cash Ratio | -- | 3.53x | 10.56x | 6.01x | 7.52x | 3.73x | |
| Leverage | |||||||
| Debt / Equity | -- | -0.21x | 0.17x | 0.18x | 0.19x | 0.26x | |
| Interest Coverage | -- | -17.64x | -21.44x | -25.10x | -26.96x | -32.58x | |
| Equity Multiplier | -- | -0.64x | 1.26x | 1.32x | 1.29x | 1.40x | |
| Efficiency | |||||||
| Asset Turnover | -- | 0.23x | 0.10x | 0.12x | 0.14x | 0.16x | |
| Inventory Turnover | -- | 3.01x | 2.35x | 1.93x | 1.79x | 1.93x | |
| Op CF / Net Income | -- | 1.04x | 0.99x | 0.62x | 1.50x | 0.70x | |
| Investment | |||||||
| Capex / Revenue | -- | 4.5% | 2.6% | 1.5% | 1.3% | 4.0% | |
| R&D / Revenue | -- | 34.4% | 34.0% | 34.7% | 32.1% | 31.9% | |
| SG&A / Revenue | -- | 92.8% | 111.0% | 103.3% | 102.5% | 103.2% | |
Revenue CAGR
+11.9%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+17.5%